| Pamela Tuli, MD | |
|
1340 Broad Ave, Suite 270, Gulfport, MS 39501-2404 | |
| (228) 575-1234 | |
| (228) 575-1240 |
| Full Name | Pamela Tuli |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 26 Years |
| Location | 1340 Broad Ave, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962684555 | NPI | - | NPPES |
| 20691 | Other | MS | BOARD OF MEDICAL LICENSURE |
| 0096512 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD072247L (Pennsylvania) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 20691 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital At Gulfport | 2466524012 | 376 |
News Archive
The Department of Physiotherapy of the University of Valencia, in collaboration with the Institute of Biomechanics of Valencia, has determined the limit pressure point to which different parts of the foot can be subjected before feeling discomfort.
Black patients with atrial fibrillation are significantly less likely to receive oral anticoagulants-particularly newer, more effective versions-than white and Hispanic patients, according to a new study published today in JAMA Cardiology.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
› Verified 2 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
The Department of Physiotherapy of the University of Valencia, in collaboration with the Institute of Biomechanics of Valencia, has determined the limit pressure point to which different parts of the foot can be subjected before feeling discomfort.
Black patients with atrial fibrillation are significantly less likely to receive oral anticoagulants-particularly newer, more effective versions-than white and Hispanic patients, according to a new study published today in JAMA Cardiology.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Tuli, MD Po Box 1810, Gulfport, MS 39502-1810 Ph: (228) 575-1234 | Pamela Tuli, MD 1340 Broad Ave, Suite 270, Gulfport, MS 39501-2404 Ph: (228) 575-1234 |
News Archive
The Department of Physiotherapy of the University of Valencia, in collaboration with the Institute of Biomechanics of Valencia, has determined the limit pressure point to which different parts of the foot can be subjected before feeling discomfort.
Black patients with atrial fibrillation are significantly less likely to receive oral anticoagulants-particularly newer, more effective versions-than white and Hispanic patients, according to a new study published today in JAMA Cardiology.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
› Verified 2 days ago
Dr. Nabil Azar, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 310, Gulfport, MS 39501 Phone: 228-575-1400 Fax: 228-575-1414 | |
Dr. Fahad Javed, M.D., Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4215 15th St, Gulfport, MS 39501 Phone: 228-863-5211 Fax: 228-863-4101 | |
Indrajit J Patel, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 | |
James K. Campbell, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 240, Gulfport, MS 39503 Phone: 228-575-7104 Fax: 228-539-6766 | |
Dr. Thomas Blanks, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1110 Broad Ave, Suite 700, Gulfport, MS 39501 Phone: 228-864-0314 Fax: 228-864-0425 | |
Dr. Stephanie Fussell, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave Ste 330, Gulfport, MS 39501 Phone: 228-575-1234 Fax: 228-867-4828 | |
Dr. Malcolm Scott Dean, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 |